Skip to main content

Table 2 Univariate survival analysis of comorbidities, medications and their interactions with surgery

From: Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma

  

Overall survival

EC-specific survival

Non-EC specific survival

Variables

No. (%)

HR(95% CI)1

P 1

HR(95% CI)1

P 1

HR(95% CI)1

P 1

Hypertension

620(52.8)

0.92(0.76-1.11)

0.38

0.92(0.73-1.16)

0.47

0.91(0.66-1.26)

0.57

Interaction with surgery

 

1.18(0.88-1.60)

0.27

1.00(0.69-1.45)

1.00

1.67(0.99-2.81)

0.05

CAD

184(15.7)

1.00(0.80-1.25)

0.99

0.88(0.66-1.16)

0.36

1.26(0.86-1.84)

0.24

Interaction with surgery

 

1.05(0.67-1.66)

0.83

0.94(0.51-1.70)

0.83

1.29(0.63-2.64)

0.49

AF

63(5.4)

1.23(0.89-1.71)

0.22

0.84(0.53-1.34)

0.48

2.19(1.36-3.51)

<0.01

Interaction with surgery

 

0.63(0.28-1.44)

0.28

0.57(0.17-1.95)

0.37

0.68(0.22-2.05)

0.49

COPD

65(5.5)

1.14(0.80-1.62)

0.47

0.69(0.40-1.18)

0.17

2.22(1.37-3.59)

<0.01

Interaction with surgery

 

0.66(0.29-1.52)

0.33

0.66(0.19-2.31)

0.51

0.68(0.22-2.08)

0.50

Asthma

36(3.1)

1.09(0.68-1.75)

0.71

0.79(0.41-1.53)

0.48

1.81(0.92-3.56)

0.09

Interaction with surgery

 

1.38(0.59-3.22)

0.46

1.80(0.59-5.46)

0.30

0.93(0.25-3.56)

0.92

Diabetes

193(16.4)

1.10(0.87-1.40)

0.43

1.13(0.85-1.51)

0.39

1.04(0.68-1.61)

0.84

Interaction with surgery

 

0.98(0.64-1.50)

0.92

0.72(0.42-1.26)

0.25

1.59(0.81-3.15)

0.18

Hypothyroidism/levothyroxine

102(8.7)

0.59(0.42-0.83)

<0.01

0.52(0.33-0.80)

<0.01

0.74(0.43-1.29)

0.29

Interaction with surgery

 

2.26(1.32-3.86)

<0.01

2.27(1.14-4.52)

0.02

2.21(0.94-5.21)

0.07

ACEi/ARB

350(29.8)

0.99(0.81-1.21)

0.95

0.94(0.73-1.20)

0.60

1.10(0.78-1.56)

0.58

Interaction with surgery

 

1.06(0.76-1.47)

0.72

0.97(0.64-1.46)

0.87

1.28(0.74-2.22)

0.38

beta-Blocker

217(18.5)

0.95(0.76-1.18)

0.65

1.05(0.81-1.36)

0.73

0.74(0.49-1.12)

0.16

Interaction with surgery

 

1.07(0.71-1.61)

0.73

0.71(0.42-1.21)

0.21

2.29(1.18-4.43)

0.01

Calcium antagonist

172(14.7)

1.01(0.79-1.30)

0.92

1.05(0.78-1.42)

0.73

0.94(0.60-1.48)

0.79

Interaction with surgery

 

1.24(0.82-1.86)

0.31

1.06(0.63-1.77)

0.82

1.63(0.82-3.23)

0.16

alpha-1-Adrenoceptor blocker

105(8.9)

1.19(0.90-1.58)

0.23

1.08(0.76-1.55)

0.67

1.45(0.90-2.32)

0.12

Interaction with surgery

 

1.12(0.67-1.87)

0.66

1.05(0.54-2.04)

0.89

1.20(0.54-2.70)

0.65

Diuretic

200(17.0)

1.01(0.80-1.26)

0.96

0.93(0.7-1.24)

0.63

1.13(0.77-1.66)

0.53

Interaction with surgery

 

1.18(0.79-1.77)

0.42

1.27(0.77-2.08)

0.35

1.07(0.53-2.16)

0.85

Cardiac glycoside

48(4.1)

1.04(0.72-1.51)

0.83

0.67(0.38-1.17)

0.16

1.83(1.11-3.04)

0.02

Interaction with surgery

 

2.09(0.94-4.62)

0.07

2.41(0.77-7.51)

0.13

1.82(0.59-5.60)

0.30

Coronary vasodilator

33(2.8)

0.61(0.36-1.04)

0.07

0.67(0.35-1.25)

0.21

0.50(0.19-1.36)

0.18

Interaction with surgery

 

1.66(0.66-4.15)

0.28

0.69(0.15-3.18)

0.63

3.89(1.02-14.88)

0.05

Bronchodilator

33(2.8)

1.34(0.84-2.15)

0.22

0.53(0.22-1.27)

0.15

3.35(1.89-5.93)

<0.01

Interaction with surgery

 

0.73(0.27-1.98)

0.53

2.05(0.54-7.74)

0.29

0.21(0.03-1.62)

0.13

Insulin

37(3.2)

0.81(0.47-1.37)

0.43

0.66(0.32-1.32)

0.24

1.17(0.52-2.65)

0.71

Interaction with surgery

 

1.87(0.67-5.25)

0.23

1.27(0.27-6.07)

0.76

2.76(0.67-11.31)

0.16

Sulfonylurea

75(6.4)

1.34(0.95-1.88)

0.09

1.53(1.04-2.26)

0.03

0.94(0.46-1.93)

0.87

Interaction with surgery

 

0.71(0.37-1.37)

0.31

0.35(0.13-0.92)

0.03

2.02(0.73-5.59)

0.18

Biguanide

104(8.9)

0.99(0.70-1.40)

0.97

1.11(0.75-1.65)

0.60

0.74(0.36-1.51)

0.41

Interaction with surgery

 

0.85(0.48-1.49)

0.57

0.62(0.31-1.26)

0.19

1.62(0.60-4.35)

0.34

Antacid

657(56.0)

0.74(0.62-0.89)

<0.01

0.79(0.63-0.99)

0.04

0.67(0.48-0.92)

0.01

Interaction with surgery

 

1.25(0.92-1.69)

0.15

1.21(0.84-1.76)

0.31

1.30(0.77-2.19)

0.30

NSAIDs

507(43.2)

1.10(0.92-1.33)

0.30

1.06(0.84-1.33)

0.63

1.19(0.86-1.64)

0.30

Interaction with surgery

 

0.90(0.66-1.22)

0.50

0.89(0.61-1.29)

0.54

0.94(0.55-1.6)

0.82

Statins

400(34.1)

0.84(0.69-1.02)

0.08

0.81(0.64-1.04)

0.09

0.87(0.62-1.23)

0.43

Interaction with surgery

 

1.19(0.86-1.64)

0.30

1.05(0.70-1.56)

0.81

1.53(0.89-2.66)

0.13

Variables

NO. (%)

HR(95%CI) 1

P 1

HR(95%CI) 1

P 1

HR(95%CI) 1

P 1

Other lipid-regulating agents

60(5.1)

0.88(0.55-1.41)

0.60

1.08(0.64-1.82)

0.77

0.46(0.15-1.45)

0.19

Interaction with surgery

 

0.75(0.36-1.56)

0.45

0.41(0.16-1.07)

0.07

2.53(0.64-10.06)

0.19

Antithrombotic

119(10.1)

0.99(0.75-1.30)

0.94

0.86(0.61-1.22)

0.40

1.29(0.83-2.00)

0.25

Interaction with surgery

 

1.03(0.59-1.80)

0.93

0.91(0.43-1.93)

0.80

1.19(0.51-2.78)

0.68

Antidepressant

215(18.3)

0.99(0.79-1.24)

0.92

0.98(0.74-1.30)

0.91

1.01(0.67-1.50)

0.97

Interaction with surgery

 

1.06(0.72-1.57)

0.76

0.89(0.55-1.47)

0.66

1.43(0.75-2.73)

0.27

  1. 1Other factors analyzed in univariate analysis include: age, sex, race, BMI, heavy alcohol use history, smoking at diagnosis, second malignancy, Karnofsky performance scores, tumor histology, tumor location, tumor differentiation, clinical stage, induction chemotherapy, radiation modality and their interactions with surgery.
  2. EC: esophageal carcinoma; HR: hazard rate; CI: confidence interval; CAD: coronary artery disease; AF: atrial fibrillation; COPD: chronic obstructive pulmonary disease; ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; NSAIDs: non-steroidal anti-inflammatory drugs.